Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
YGD
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
YGD is a mixed herbal preparation containing Yerbe Maté (leaves of Ilex paraguayensis), Guarana (seeds of Paullinia cupana), and Damiana (leaves of Turnera diffusa var. aphrodisiaca). It is being investigated for its effects on weight loss and weight maintenance in overweight and obese patients. The preparation works by significantly delaying gastric emptying, which in turn reduces the time to perceived gastric fullness and leads to a reduction in body weight. Clinical studies have shown its efficacy in inducing weight loss over 45 days and maintaining weight over 12 months.
- Brand names
- Zotrim
- Other names
- Yerbe Maté, Guarana and Damiana
Beyond the preview
Go deeper on YGD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on YGD.